Navigation Links
Ganeden Biotech Teams Up with Connell Brothers to Take On Food Ingredients Asia 2013

Cleveland, OH (PRWEB) September 04, 2013

As they expand their presence in Asia, Ganeden Biotech, in partnership with their new distribution partner, Connell Brothers, will be exhibiting at the Food Ingredients Asia tradeshow at the International Trade and Exhibition Center (BITEC) in Bangkok, Thailand on September 11-13, 2013.

“We are aggressively expanding into the Asian market and it is very exciting to be exhibiting at our first Asian tradeshow,” said Michael Bush, VP of Business Development. “The Southeast-Asian food and beverage industry is growing very rapidly; so, being able to exhibit in conjunction with our distribution partner Connell Brothers is a great way for us to increase awareness of GanedenBC30.”

Connell Brothers and Ganeden Biotech cemented their partnership in April of 2013, with Connell Brothers being the exclusive distributor of GanedenBC30 throughout Southeast and North Asia. Operating in 17 countries throughout Asia-Pacific, Connell Brothers sustains a strong presence with 37 offices and multiple warehouses spread across the region.

Food Ingredients Asia is one of the largest food and beverage industry tradeshows in the world. With a growth of 25% annually over the last four years, and over eleven thousand visitors from 56 different countries; it continues to be a key course when entering the ASEAN (Association of Southeast Asian Nations) food and beverage industry.

To learn more about GanedenBC30 and its flexible formulation options, visit booth B-1. On hand will be examples of the many popular products enriched with GanedenBC30 and Stephen Quinn, Ganeden Biotech’s International Business Development and Regulatory Manager will be available to answer any questions you may have.


About GanedenBC30
Ganeden Biotech’s probiotic, GanedenBC30 (Bacillus coagulans GBI-30, 6086), is a patented, organism that can be found in more than 80 leading food, beverage and companion animal products throughout the world. Unlike most other probiotic strains used in food and beverages, GanedenBC30 is highly stable and can remain viable through processing, shelf life and the low pH of stomach acid. The efficacy of GanedenBC30 is backed by 17 published studies. GanedenBC30 has an exceptional safety record and FDA GRAS status from the United States Food and Drug Administration. For more information, please visit

About Connell Brothers
Connell Brothers is a division of Wilbur-Ellis Company and is the largest marketer and distributor of specialty chemicals and industrial ingredients in Asia-Pacific. With over 100 years in Asia and a keen focus on technical service, customer support and quality control, Connell Brothers provides complete supply chain management from transportation, documentation, warehousing, and sales and distribution in 17 countries and in 37 offices located throughout Asia-Pacific. For more information, please visit

About Ganeden Biotech
Ganeden Biotech is at the forefront of probiotic research and product development with an extensive library of published studies and more than 100 patents for probiotic technologies in the food, beverage, animal health, and now personal care ingredients markets. Ganeden is best known for GanedenBC30® (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS, highly stable probiotic ingredient. Ganeden's newest ingredient, Bonicel, is the first science-backed, probiotic-derived, personal care ingredient shown to dramatically reduce signs of aging. For more information about Ganeden Biotech and licensing opportunities visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Probiotic-Enriched Instant Chai Latte and Teas to be Launched by Ganeden Biotech and Tipton Mills
2. Ganeden Biotech Hires New Marketing Manager
3. Ganeden Biotech® Moves Its State-Of-The-Art Lab To Its World Headquarters In Cleveland
4. Ganeden Partner Product Wins SupplySide Insights Award
5. GenWay Biotech Launches New Cardiovascular Diagnostic Blood Test at American Heart Association Scientific Sessions 2011
6. Puma Biotechnology Announces Completion of Private Placement
7. Animal Biotechnology - Technologies, Markets and Companies
8. AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug
9. The European Union Signs Grant Contract to Fund a 2 Million Euro Biotechnology Research Project Led by Hadassah College Jerusalem
10. Janssen Biotech, Inc. Announces Collaborative Development and Worldwide License Agreement for Investigational Anti-Cancer Drug, PCI-32765
11. Puma Biotechnology Announces Positive PB272 (Neratinib) Phase II Data at CTRC-AACR San Antonio Breast Cancer Symposium
Post Your Comments:
(Date:11/26/2015)... CHESHAM , England , November 26, ... Lightpoint Medical, an innovative medical device company specializing in ... Euro grant from the European Commission as part of the ... enabling the company to carry out a large-scale clinical trial ... -->      (Logo: , ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... Studies reveal the differences in species of ... way for more effective treatment for one of the most ... --> --> Gum disease is ... yet relatively little was understood about the bacteria associated with ... by researchers from the WALTHAM Centre for Pet Nutrition together ...
(Date:11/25/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... CEO of Neurocrine Biosciences, will be presenting at the ... New York . .   ... 5 minutes prior to the presentation to download or ... will be available on the website approximately one hour ...
Breaking Biology Technology:
(Date:11/12/2015)... 12, 2015  A golden retriever that stayed healthy ... (DMD) has provided a new lead for treating this ... Broad Institute of MIT and Harvard and the University ... Cell, pinpoints a protective gene ... disease,s effects. The Boston Children,s lab of Lou ...
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
Breaking Biology News(10 mins):